Amantadine monotherapy of chronic hepatitis C patients infected with genotype 1b

Authors
Senturk, H Mert, A Akdogan, M Tabak, F Basaran, G Turkoglu, S Ozbay, G Badur, S
Citation
H. Senturk et al., Amantadine monotherapy of chronic hepatitis C patients infected with genotype 1b, SC J IN DIS, 32(5), 2000, pp. 575-576
Citations number
7
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
ISSN journal
00365548 → ACNP
Volume
32
Issue
5
Year of publication
2000
Pages
575 - 576
Database
ISI
SICI code
0036-5548(2000)32:5<575:AMOCHC>2.0.ZU;2-P
Abstract
We aimed to test the efficacy of amantadine in chronic hepatitis C (CHC) pa tients infected with genotype Ib. Twenty patients completed treatment with amantadine HCl, 100 mg b.i.d., for 6 months. Non-sustained biochemical impr ovement was observed without loss of HCV-RNA, We conclude that amantadine m onotherapy is not effective in CHC.